top of page

A Fusion Deal: NHiS sold to Wilmington Group

Updated: Feb 26, 2018

Fusion Corporate Partners are pleased to announce the acquisition of NHiS Limited by Wilmington Group plc. Fusion acted exclusively for the shareholders of NHiS Limited. The Fusion team responsible for the transaction were led by Mark Eisenstadt.

Wilmington Group will pay an initial cash consideration of £5.6m and a further deferred consideration of up to £3.75m subject to the Business achieving targets for the growth in underlying profit. 

The deferred consideration will be satisfied by issuing of up to 1.5m new Wilmington Group plc shares in October 2016 dependent interalia upon NHiS’s audited future earnings for the years ended 30th June 2015 and 30th June 2016. The Business was acquired with cash of £0.6m and the initial consideration will be financed out of the Group’s existing £65m debt facility.

The existing executive management team led by Nick Merryfield, the founding Managing Director, and Paul Midgley will remain with the business and they, along with five other individuals, comprise the vendors of the Business.

Nick Merryfield, talking about the process said, “I must thank Fusion for orchestrating the sale process professionally and with great skill. As a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK we wanted to work with an M&A house that understood our business and the marketplace. Mark was our point man and was key in engineering a successful outcome.”

NHiS has been in operation since 2007 and is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK. Around 40% of its revenue is derived from subscriptions and the business has enjoyed high overall renewal rates as defined by customer spend in excess of 90%. Over 75% of NHiS revenue is delivered digitally.

The Business will form part of the Wilmington Healthcare Division and will work closely with the highly complementary Binley’s Healthcare Information business.

NHiS’s last annual results to March 2012, showed revenue of £1.8m, up 45% from the prior year and profits before tax and nonrecurring costs of £0.8m. The Business has seen a strong start to the year and turnover for the first nine months increased by 20%. Deferred income as 31st December 2012 was up 50% on 31st December 2011. Gross Assets at 31st March 2012 were £1.6m. 

Charlie Brady, Chief Executive of Wilmington Group, said;

“NHiS is an innovative business that has built up a major business intelligence and technology capability in a complementary area where our own Binleys Healthcare Information continues to see good growth potential. The Business will benefit from being part of a larger group with the infrastructure and resources of Binleys. We are particularly pleased that the existing highly experienced management team are joining the Wilmington Group and look forward to working with them as they continue to develop NHiS”.

4 views0 comments

Recent Posts

See All

Fusion Deal: Legal Monitor sold to Law Business Research

Law Business Research Ltd (LBR) acquisition of Worldwide Legal Research (WLR) London – Law Business Research Ltd (LBR), a portfolio company of Levine Leichtman Capital Partners VI, LP (LLCP), has acqu


bottom of page